Stage 2 · industry
Stage 2 Stocks in Biotechnology
111 US stocks in Biotechnology are in Stage 2, the advancing phase of Weinstein's stage analysis. Listed below: those priced at $5 or more and trading at least $1 million a day on average, ranked by setup score and updated after every close (last close Oct 23, 2026).
| Stock | Close | 1D | Setup | Weeks in stage |
|---|---|---|---|---|
| EXEL Exelixis, Inc. | $64.53 | -1.19% | 8.3 | 26 |
| FTRE Fortrea Holdings Inc. | $23.63 | -1.21% | 8.3 | 20 |
| SLN Silence Therapeutics Plc | $19.67 | +0.05% | 8.2 | 1 |
| HALO Halozyme Therapeutics, Inc. | $125.63 | +0.88% | 7.8 | 16 |
| PBYI Puma Biotechnology Inc | $11.02 | -2.13% | 7.5 | 69 |
| IOVA Iovance Biotherapeutics, Inc. | $14.09 | -0.35% | 7.5 | 19 |
| GMAB Genmab A/S | $43.79 | +9.47% | 7.4 | 9 |
| MRNA Moderna, Inc. | $200.10 | -1.25% | 7.1 | 17 |
| PCVX Vaxcyte, Inc. | $60.43 | -3.85% | 7.1 | 12 |
| VSTM Verastem, Inc. | $10.04 | -0.20% | 7.0 | 7 |
| ARQT Arcutis Biotherapeutics, Inc. | $31.20 | -3.11% | 6.9 | 1 |
| DMAC DiaMedica Therapeutics Inc. | $8.72 | +1.04% | 6.8 | 2 |
| CAI Caris Life Sciences, Inc. | $32.00 | +0.91% | 6.8 | 6 |
| DNA Ginkgo Bioworks Holdings, Inc. Class A | $9.99 | +2.88% | 6.6 | 3 |
| KOD Kodiak Sciences Inc | $87.63 | +2.16% | 6.5 | 4 |
| TECH Bio-Techne Corp | $72.55 | -0.10% | 6.5 | 13 |
| RPRX Royalty Pharma plc Class A | $63.86 | +0.17% | 6.2 | 49 |
| NVAX Novavax, Inc. | $9.70 | -2.90% | 6.2 | 5 |
| RIGL Rigel Pharmaceuticals, Inc. | $48.13 | -1.49% | 6.1 | 14 |
| IBRX ImmunityBio, Inc. | $8.22 | -1.08% | 6.0 | 9 |
| XNCR Xencor, Inc. | $25.18 | -2.55% | 5.7 | 14 |
| NRXS Neuraxis, Inc. | $7.40 | -2.63% | 5.6 | 3 |
| ONC BeOne Medicines Ltd. | $377.63 | -1.21% | 5.6 | 9 |
| LGND Ligand Pharmaceuticals Incorporated | $303.53 | -1.39% | 5.5 | 1 |
| IRLA IRulya Therapeutics Inc. | $33.08 | +0.76% | 5.4 | 2 |
| AUPH Aurinia Pharmaceuticals Inc | $16.86 | -2.71% | 5.0 | 4 |
| OBIO Orchestra BioMed Holdings, Inc. | $5.59 | +2.19% | 5.0 | 9 |
| TWST Twist Bioscience Corporation | $139.92 | +3.28% | 5.0 | 39 |
| MRVI Maravai LifeSciences Holdings, Inc. Class A | $7.32 | +3.54% | 4.9 | 25 |
| ZYME Zymeworks Inc. | $28.22 | -0.77% | 4.9 | 9 |
| KRSA Korsana Biosciences, Inc. | $31.31 | -6.34% | 4.8 | 26 |
| VRTX Vertex Pharmaceuticals Incorporated | $523.93 | -2.10% | 4.8 | 17 |
| TTRX Turn Therapeutics Inc. | $10.28 | +0.98% | 4.8 | 13 |
| TGTX TG Therapeutics, Inc. | $54.17 | +1.90% | 4.8 | 25 |
| OMER Omeros Corporation | $16.57 | -1.72% | 4.6 | 10 |
| ZLAB Zai Lab Limited | $24.03 | +9.03% | 4.5 | 10 |
| VIR Vir Biotechnology, Inc. | $10.57 | +1.34% | 4.5 | 9 |
| REGN Regeneron Pharmaceuticals, Inc. | $805.02 | -1.72% | 4.4 | 8 |
| HRMY Harmony Biosciences Holdings, Inc. | $36.13 | +0.28% | 4.4 | 17 |
| REPL Replimune Group, Inc. | $11.46 | -4.42% | 4.3 | 16 |
| PGEN Precigen, Inc. | $6.19 | -3.13% | 4.3 | 22 |
| ABCL AbCellera Biologics Inc. | $11.82 | +3.96% | 4.3 | 21 |
| ARCT Arcturus Therapeutics Holdings Inc. | $9.84 | -8.29% | 4.2 | 9 |
| DRTS Alpha Tau Medical Ltd. | $13.16 | +2.02% | 4.1 | 70 |
| ORIC Oric Pharmaceuticals, Inc. | $13.17 | -3.37% | 4.0 | 10 |
| SEPN Septerna, Inc. | $40.41 | -1.15% | 3.9 | 20 |
| TARS Tarsus Pharmaceuticals, Inc. | $68.20 | -5.38% | 3.9 | 5 |
| FDMT 4D Molecular Therapeutics, Inc. | $10.80 | -8.86% | 3.9 | 30 |
| HELP Helus Pharma Inc. | $10.19 | -2.95% | 3.9 | 12 |
| KYMR Kymera Therapeutics, Inc. | $110.76 | -0.08% | 3.9 | 18 |
| ARGX argenx SE | $873.71 | -0.23% | 3.9 | 19 |
| ACOG Alpha Cognition Inc. | $8.34 | +0.36% | 3.9 | 17 |
| RVMD Revolution Medicines, Inc. | $186.99 | -0.37% | 3.9 | 27 |
| AGEN Agenus Inc. | $6.33 | -2.77% | 3.9 | 13 |
| JANX Janux Therapeutics, Inc. | $16.66 | -2.34% | 3.8 | 9 |
| KURA Kura Oncology, Inc. | $9.61 | -2.54% | 3.8 | 18 |
| CORT Corcept Therapeutics Incorporated | $85.86 | -20.13% | 3.8 | 18 |
| ACHV Achieve Life Sciences, Inc. | $6.49 | -0.15% | 3.8 | 24 |
| EPRX Eupraxia Pharmaceuticals Inc. | $6.87 | -9.49% | 3.7 | 3 |
| ABSI Absci Corporation | $9.18 | -2.03% | 3.7 | 3 |
Biotechnology: quick answers
Which stocks in Biotechnology are in an uptrend?
As of Oct 23, 2026, 111 US stocks in Biotechnology are in Stage 2, the uptrend phase. The largest by market value are Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna, argenx and BeOne Medicines.
How many stocks in Biotechnology are in Stage 2?
111 of the 591 stocks we track in Biotechnology (18.8%) are in Stage 2. 45 are basing in Stage 1, 110 are topping in Stage 3 and 291 are in a Stage 4 downtrend. That share has fallen 8.1 points over the last 20 sessions.
Which stocks in Biotechnology entered Stage 2 recently?
11 stocks entered Stage 2 in the last four weeks: Silence Therapeutics (its first week), Arcutis Biotherapeutics (its first week), Ligand Pharmaceuticals (its first week), DiaMedica Therapeutics (week 2), IRulya Therapeutics (week 2) and 6 more.
Daily screens
Every one recalculated after the close, with the exact criteria published on the page.
Stage 2 in other sectors & industries
US stocks in a confirmed uptrend (Stage 2, Weinstein’s advancing phase), grouped by sector and industry and ranked by setup score.
Health Care273Information Technology238Financials213Industrials142Energy119Consumer Discretionary100Banks - Regional94Software - Application79Materials74Software - Infrastructure59Communication Services54Consumer Staples53Asset Management45Oil & Gas E&P43Medical Devices35Diagnostics & Research31Oil & Gas Midstream30Drug Manufacturers - Specialty & Generic26Marine Shipping23Gold23Semiconductors22Information Technology Services21Real Estate20Specialty Chemicals19Capital Markets18Health Information Services17Insurance - Property & Casualty17Medical Care Facilities17Medical Instruments & Supplies17Specialty Business Services16Oil & Gas Integrated15Entertainment15Specialty Industrial Machinery14Utilities13Restaurants13Oil & Gas Refining & Marketing12Furnishings, Fixtures & Appliances12Computer Hardware12Credit Services12Specialty Retail11Telecom Services11Internet Content & Information11Industrial Distribution10Household & Personal Products10Education & Training Services10Communication Equipment10Oil & Gas Equipment & Services10Drug Manufacturers - General9Internet Retail9Electronic Components9Electronics & Computer Distribution8Farm & Heavy Construction Machinery8Advertising Agencies8Electrical Equipment & Parts8Packaged Foods8Consumer Electronics7Consulting Services7Copper6Healthcare Plans6Financial Data & Stock Exchanges6REIT - Hotel & Motel6Beverages - Non-Alcoholic6Steel6Security & Protection Services6Insurance Brokers6Conglomerates6Leisure6Semiconductor Equipment & Materials6Auto Parts6Oil & Gas Drilling5Personal Services5Footwear & Accessories5Insurance - Life5Staffing & Employment Services5Electronic Gaming & Multimedia5Integrated Freight & Logistics5Scientific & Technical Instruments5Building Products & Equipment5Utilities - Regulated Electric5Real Estate Services5Engineering & Construction5Other Industrial Metals & Mining5Aerospace & Defense5